Argent Trust Co’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$508K Buy
13,828
+3,171
+30% +$150K 0.02% 467
2025
Q4
$542K Buy
10,657
+683
+7% +$34.9K 0.02% 448
2025
Q3
$553K Sell
9,974
-833
-8% -$48.8K 0.02% 442
2025
Q2
$746K Buy
10,807
+648
+6% +$44.1K 0.03% 374
2025
Q1
$705K Buy
10,159
+1,919
+23% +$158K 0.03% 373
2024
Q4
$709K Sell
8,240
-1,512
-16% -$164K 0.03% 368
2024
Q3
$1.16M Buy
9,752
+794
+9% +$106K 0.05% 290
2024
Q2
$1.28M Buy
8,958
+1,824
+26% +$242K 0.06% 271
2024
Q1
$916K Sell
7,134
-134
-2% -$16K 0.04% 322
2023
Q4
$752K Sell
7,268
-334
-4% -$33K 0.04% 335
2023
Q3
$691K Sell
7,602
-414
-5% -$36.5K 0.04% 335
2023
Q2
$649K Hold
8,016
0.04% 357
2023
Q1
$638K Sell
8,016
-2,050
-20% -$145K 0.04% 322
2022
Q4
$681K Hold
10,066
0.05% 300
2022
Q3
$502K Sell
10,066
-10
-0.1% -$536 0.04% 335
2022
Q2
$562K Buy
10,076
+142
+1% +$7.88K 0.04% 325
2022
Q1
$552K Hold
9,934
0.03% 337
2021
Q4
$556K Hold
9,934
0.03% 342
2021
Q3
$477K Buy
9,934
+128
+1% +$6.19K 0.03% 355
2021
Q2
$411K Buy
9,806
+746
+8% +$28.9K 0.03% 380
2021
Q1
$305K Sell
9,060
-236
-3% -$8.41K 0.02% 418
2020
Q4
$325K Buy
+9,296
New +$321K 0.03% 382

Other funds holding NVO

Argent Trust Co's NVO Position: Q1 2026 in Review

Argent Trust Co increased its Novo Nordisk (NVO) stake by 30% in Q1 2026, buying an estimated $150K and bringing the position to 13,828 shares worth $508K. The position accounts for 0.02% of the portfolio, ranked #467.

Argent Trust Co first reported a position in NVO in Q4 2020 and has held it in 22 quarters since. The position peaked at $1.28M in Q2 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Argent Trust Co held 13,828 shares of Novo Nordisk worth $508K as of Q1 2026.
  • Argent Trust Co bought 3,171 Novo Nordisk shares in Q1 2026, an estimated $150K.
  • Novo Nordisk made up 0.02% of Argent Trust Co's portfolio in Q1 2026, its #467 holding.
  • Argent Trust Co first reported a position in Novo Nordisk in Q4 2020 and has held it in 22 quarters since.
  • Argent Trust Co's Novo Nordisk position peaked at $1.28M in Q2 2024.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Argent Trust Co's 13F filing for Q1 2026, filed 13 May 2026.